DOJ OIG — Drug Enforcement Administration
56 documentsSource agency: doj-oig
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.
Documents — page 1 of 1
56 shown- Audit of the Drug Enforcement Administration's Accounting for Permanent Change of Station Transfers
- Audit of the Drug Enforcement Administration's Adoptive Seizure Process and Status of Related Equitable Sharing Requests
- Audit of the Drug Enforcement Administration's Asset Forfeiture Program Task Orders Awarded to Maximus, Inc., for Financial Investigative Services
- Audit of the Drug Enforcement Administration’s Authorized Central Storage Program
- Audit of the Drug Enforcement Administration's Aviation Division Office Internet System Pursuant to the Federal Information Security Modernization Act of 2014 Fiscal Year 2018
- Audit of the Drug Enforcement Administration's Aviation Operations
- Audit of the Drug Enforcement Administration's Aviation Operations with the Department of Defense in Afghanistan
- Audit of the Drug Enforcement Administration’s Community-Based Efforts to Combat the Opioid Crisis
- Audit of the Drug Enforcement Administration's Confidential Source Policies and Oversight of Higher-Risk Confidential Sources
- Audit of the Drug Enforcement Administration's Controls Over Seized and Collected Drugs
- Audit of the Drug Enforcement Administration's Controls over Weapons and Munitions
- Audit of the Drug Enforcement Administration’s El Paso Intelligence Center Seizure System Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2024
- Audit of the Drug Enforcement Administration’s Headquarters-Based Oversight of its Supported Foreign Law Enforcement Units
- Audit of the Drug Enforcement Administration's Income-Generating, Undercover Operations
- Audit of the Drug Enforcement Administration’s Information Security Management Program Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2024
- Audit of the Drug Enforcement Administration's Information Security Program Pursuant to the Federal Information Security Modernization Act of 2014 Fiscal Year 2018
- Audit of the Drug Enforcement Administration's Information Security Program Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2021
- Audit of the Drug Enforcement Administration’s Laboratory Information Management System Support Contracts
- Audit of the Drug Enforcement Administration's Language Services Contract with SOS International, Ltd., Contract Number DJDEA-05-C-0020, Dallas Field Division
- Audit of the Drug Enforcement Administration's Management and Oversight of its Confidential Source Program
- Audit of the Drug Enforcement Administration's Personnel Resource Management and Casework
- Audit of the Drug Enforcement Administration's Prescription Drug Take Back Activities
- Audit of the Drug Enforcement Administration's Regional Linguist Services Contract Awarded to Conduit Language Specialists, Inc.
- Audit of the Drug Enforcement Administration's Spider Core System Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2021
- Audit of the Drug Enforcement Administration’s Use of Polygraphs in the Pre-employment and Foreign Vetting Processes
- Bonuses and Other Favorable Personnel Actions for Drug Enforcement Administration Employees Involved in Alleged Sexual Misconduct Incidents Referenced in the OIG's March 2015 Report
- Drug Enforcement Administration Annual Financial Statement - Fiscal Year 2009
- Drug Enforcement Administration Annual Financial Statements Fiscal Year 2011
- Drug Enforcement Administration Annual Financial Statements Fiscal Year 2012
- The Drug Enforcement Administration's Adjudication of Registrant Actions
- The Drug Enforcement Administration's Clandestine Drug Laboratory Cleanup Program
- Findings of Misconduct by a then Drug Enforcement Administration Regional Director for Misuse of Sensitive Investigative Unit Funds, Misuse of Representation Funds, Lack of Candor in Request for Representation Funds, and Related Misconduct
- Follow-up Audit of the Drug Enforcement Administration's Handling of Cash Seizures
- Follow-up Review of the Drug Enforcement Administration's El Paso Intelligence Center
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration Assistant Special Agent in Charge for Violating the Anti-Nepotism Statute and DEA Personal Conflict of Interest Policy
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration (DEA) Executive Assistant for Misuse of Position, Prohibited Association with a Former DEA Confidential Source, and Soliciting and Accepting Gifts from the Former DEA Confidential Source
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration Special Agent in Charge for Installing and Remotely Monitoring an Unauthorized Personally-Owned Camera in the DEA Office
- Investigative Summary: Findings of Misconduct by a then Drug Enforcement Administration Assistant Special Agent in Charge for Having an Inappropriate, Intimate Relationship with a Subordinate, Obstruction, Lack of Candor, and Related Misconduct
- Investigative Summary: Findings of Misconduct by a then Senior Official with the Drug Enforcement Administration for Misuse of Official Position Related to Giving Preferential Treatment to a Pharmaceutical Company, and Related Misconduct
- Management Advisory Memorandum – Notification of Concerns Identified in the Drug Enforcement Administration’s Use of Polygraph Examinations in Pre-employment Vetting
- Management Advisory Memorandum – Notification of Concerns Relating to the DEA’s Untimely Reporting of Potential Human Rights Violations by Foreign Law Enforcement
- Memorandum for the Deputy Attorney General: Recommendation for the Drug Enforcement Administration to Review whether its Field Offices are Engaging in Unlawful Fundraising on Behalf of the Drug Enforcement Administration Survivors Benefit Fund
- Notification of Concerns Identified in the Drug Enforcement Administration’s Transportation Interdiction Activities
- Procedural Reform Recommendation for the U.S. Marshals Service, Superior Court of the District of Columbia
- Public Summary of the Addendum to the Audit of the Drug Enforcement Administration's Management and Oversight of its Confidential Source Program
- Report of Investigation of the Actions of Former DEA Leadership in Connection with the Reinstatement of a Security Clearance
- Report of Investigation Regarding the DEA's Relationship with K. Wayne McLeod
- Review of the Drug Enforcement Administration's Accounting of Drug Control Funding Fiscal Year 2024
- Review of the Drug Enforcement Administration’s Accounting of Drug Control Funding Fiscal Year 2025
- Review of the Drug Enforcement Administration's El Paso Intelligence Center
- Review of the Drug Enforcement Administration's Regulatory and Enforcement Efforts to Control the Diversion of Opioids
- A Review of the Drug Enforcement Administration's Use of Administrative Subpoenas to Collect or Exploit Bulk Data (Revised March 2025)
- Review of the Drug Enforcement Administration's Use of Cold Consent Encounters at Mass Transportation Facilities
- Review of the Organized Crime Drug Enforcement Task Forces Fusion Center
- A Special Joint Review of Post-Incident Responses by the Department of State and Drug Enforcement Administration to Three Deadly Force Incidents in Honduras
- Summary of OIG Investigative Findings Regarding the Detention by the Drug Enforcement Administration of Daniel Chong
About this collection
Documents in the DOJ OIG — Drug Enforcement Administration collection were released by the National Archives as part of ongoing declassification programs. Each file retains its original NARA Record Identification Number so it can be cross-referenced against academic and journalistic citations. Use the pagination below to walk the full 56-record list, or jump to any individual document for metadata and an in-browser PDF preview.
Frequently asked questions
What is the DOJ OIG — Drug Enforcement Administration collection?
DOJ OIG — Drug Enforcement Administration is a set of 56 declassified documents released by the DOJ Office of the Inspector General. Each record is indexed by BlackVaultDocs with its original identifier so it can be cross-referenced against agency citations.
Are the PDFs hosted on BlackVaultDocs?
No. Every PDF link points to the canonical file on the originating agency's website. BlackVaultDocs stores only the metadata — title, identifier, release date, and collection — so researchers can search and cite without mirroring the primary source.